Intract Pharma Ltd

NW1 0NH (London)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£1,575,306

Dec 21 - Nov 25

Targeting the pathogenic Th17 cell axis in autoimmunity:developing a portfolio of novel, rationally designed and innovatively delivered biologics

FLF award to Elasmogen Ltd and Obinna Ubah

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}